Model Portfolios | Institutional | News | Contact

AGNG

Aging Population ETF

Overview Prices & Performance Holdings & Characteristics Research Documents

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2021

Key Information As of 05/26/23

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$55.57 million
NAV	$27.24
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 05/25/23

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	2,040,000
Number of Holdings	94
30-Day Median Bid-Ask Spread	0.35%

Distributions As of 05/26/23

30-Day SEC Yield	0.83%
Distribution Frequency	Semi-Annually

ETF Prices As of 05/26/23

NAV	$27.24	Daily Change	-$0.01	-0.04%
Market Price	$27.23	Daily Change	$0.02	0.07%

As of recent (03/31/23) As of recent (03/31/23)	Fund NAV	Market Price	Index
1 Year	-5.77%	-6.05%	-5.58%
3 Years	10.49%	10.40%	10.73%
5 Years	7.13%	6.99%	7.35%
Since Inception	9.37%	9.65%	9.64%
1 Year	6.54%	6.27%	6.76%
3 Years	8.36%	8.35%	8.58%
5 Years	8.48%	8.38%	8.70%
Since Inception	10.03%	10.33%	10.31%
Year-to-Date	2.40%	2.29%	2.45%
1 Month	2.44%	2.33%	2.44%
3 Months	2.40%	2.29%	2.45%
Since Inception	85.42%	88.76%	88.63%
Year-to-Date	7.62%	7.64%	7.68%
1 Month	5.10%	5.23%	5.11%
3 Months	4.79%	4.80%	4.82%
Since Inception	94.87%	98.62%	98.27%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
3.56	LLY	ELI LILLY & CO	2516152	425.79	3,960	1,686,128.40
3.42	ALC SW	ALCON INC	BJT1GR5	79.02	20,526	1,621,896.80
3.31	4519 JP	CHUGAI PHARMA CO	6196408	26.71	58,674	1,567,340.63
3.21	BIIB	BIOGEN INC	2455965	298.66	5,095	1,521,672.70
3.11	MDT	MEDTRONIC PLC	BTN1Y11	81.46	18,087	1,473,367.02
3.07	WELL	WELLTOWER INC	BYVYHH4	73.54	19,797	1,455,871.38
3.07	BSX	BOSTON SCIENTIFIC CORP	2113434	51.06	28,475	1,453,933.50
3.06	DXCM	DEXCOM INC	B0796X4	115.05	12,591	1,448,594.55
3.06	NOVOB DC	NOVO NORDISK A/S-B	BHC8X90	163.49	8,857	1,448,035.87
3.00	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	72.52	19,610	1,422,117.20
3.00	EW	EDWARDS LIFESCIENCES CORP	2567116	82.01	17,308	1,419,429.08
2.90	SGEN	SEAGEN INC	BLPK4D2	193.49	7,107	1,375,133.43
2.89	SYK	STRYKER CORP	2853688	272.58	5,027	1,370,259.66
2.87	JNJ	JOHNSON & JOHNSON	2475833	154.35	8,819	1,361,212.65
2.80	BMY	BRISTOL-MYERS SQUIBB CO	2126335	63.82	20,789	1,326,753.98
2.73	REGN	REGENERON PHARMACEUTICALS	2730190	725.05	1,786	1,294,939.30
2.66	AMGN	AMGEN INC	2023607	216.93	5,809	1,260,146.37
2.66	RO SW	ROCHE HOLDING AG-BR	7108918	347.02	3,631	1,260,032.85
2.62	ABBV	ABBVIE INC	B92SR70	137.56	9,009	1,239,278.04
2.15	4503 JP	ASTELLAS PHARMA INC	6985383	16.51	61,694	1,018,536.13
1.93	ZBH	ZIMMER BIOMET HO	2783815	127.65	7,181	916,654.65
1.92	GMAB DC	GENMAB A/S	4595739	405.28	2,240	907,820.99
1.77	BGNE	BEIGENE LTD-ADR	BYYWPW6	236.90	3,536	837,678.40
1.73	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	150.86	5,446	821,567.66
1.59	4543 JP	TERUMO CORP	6885074	29.52	25,586	755,223.62
1.38	068270 KS	CELLTRION INC	B0C5YV1	130.70	4,990	652,156.16
1.35	PODD	INSULET CORP	B1XGNW4	272.63	2,352	641,225.76
1.24	UCB BB	UCB SA	5596991	88.96	6,617	588,665.77
1.23	VTR	VENTAS INC	2927925	42.88	13,611	583,639.68
1.16	SOON SW	SONOVA HOLDING AG-REG	7156036	263.13	2,082	547,840.38
1.05	EXAS	EXACT SCIENCES CORP	2719951	82.01	6,071	497,882.71
1.00	INCY	INCYTE CORP	2471950	62.58	7,588	474,857.04
0.95	SN/ LN	SMITH & NEPHEW PLC	0922320	15.11	29,783	450,122.29
0.91	FME GR	FRESENIUS MEDICA	5129074	43.09	9,993	430,594.42
0.79	TFX	TELEFLEX INC	2881407	232.35	1,612	374,548.20
0.76	COH AU	COCHLEAR LTD	6211798	159.43	2,252	359,044.44
0.69	UTHR	UNITED THERAPEUTICS CORP	2430412	207.32	1,582	327,980.24
0.69	3692 HK	HANSOH PHARMACEU	BJYKB72	1.65	198,643	327,570.73
0.67	DEMANT DC	DEMANT A/S	BZ01RF1	39.19	8,055	315,684.88
0.63	NBIX	NEUROCRINE BIOSC	2623911	91.22	3,287	299,840.14
0.61	DVA	DAVITA INC	2898087	94.28	3,061	288,591.08
0.60	AGL	AGILON HEALTH INC	BLR4TK4	20.26	14,075	285,159.50
0.58	AMP IM	AMPLIFON SPA	B14NJ71	35.33	7,830	276,619.21
0.55	NVCR	NOVOCURE LTD	BYSS4X4	73.56	3,568	262,462.08
0.47	OHI	OMEGA HEALTHCARE	2043274	28.33	7,913	224,175.29
0.44	EXEL	EXELIXIS INC	2576941	19.13	10,992	210,276.96
0.41	ACAD	ACADIA PHARMACEU	2713317	24.78	7,850	194,523.00
0.38	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	57.75	3,103	179,198.25
0.37	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	29.96	5,897	176,674.12
0.36	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	88.57	1,939	171,737.23
0.35	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	25.82	6,503	167,907.46
0.35	ALEC	ALECTOR INC	BJ4LDC4	7.59	22,116	167,860.44
0.35		KOREAN WON		0.00	219,868,938	166,007.73
0.34	GKOS	GLAUKOS CORP	BYMWL19	54.85	2,967	162,739.95
0.34	GN DC	GN STORE NORD A/S	4501093	25.80	6,278	161,998.06
0.34	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	81.44	1,959	159,540.96
0.34	MNKD	MANNKIND CORP	BF081J4	4.54	34,958	158,709.32
0.33	145720 KS	DENTIUM CO LTD	BF07GJ6	120.58	1,306	157,475.33
0.33	RYM NZ	RYMAN HEALTHCARE LTD	6161525	3.64	42,962	156,511.44
0.32	HALO	HALOZYME THERAPEUTICS INC	2975098	33.20	4,591	152,421.20
0.32	NHC	NATIONAL HEALTHCARE CORP	2139731	60.01	2,528	151,705.28
0.32	KORI FP	KORIAN	B1HKRM0	8.03	18,665	149,963.41
0.32	CSH-U CN	CHARTWELL RETIRE	B8S8C94	6.57	22,771	149,698.09
0.32	LIVN	LIVANOVA PLC	BYMT0J1	44.02	3,396	149,491.92
0.31	NHI	NATL HEALTH INVESTORS INC	2626125	51.61	2,878	148,533.58
0.31	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	8.25	17,879	147,456.21
0.31	ITGR	INTEGER HOLDINGS CORP	BD06LM7	80.37	1,817	146,032.29
0.31	SGHT	SIGHT SCIENCES INC	BN2T5Q6	9.25	15,726	145,465.50
0.30	ANGO	ANGIODYNAMICS INC	B00CR04	9.29	15,476	143,772.04
0.30	8086 JP	NIPRO CORP	6641599	7.17	19,710	141,271.72
0.30	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	7.93	17,678	140,154.69
0.29	AMED	AMEDISYS INC	2024332	77.31	1,800	139,158.00
0.29	EMBC	EMBECTA CORP	BMXWYR1	26.90	5,090	136,921.00
0.29	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	11.06	12,226	135,219.56
0.28	DCPH	DECIPHERA PHARMA	BZ1LFB2	13.79	9,751	134,466.29
0.28	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	14.32	9,228	132,144.96
0.28	CANO	CANO HEALTH INC	BN0WWW2	1.26	103,266	130,115.16
0.27	SBRA	SABRA HEALTH CAR	B5NLBP6	10.51	12,375	130,061.25
0.27	LTC	LTC PROPERTIES INC	2498788	31.22	4,164	130,000.08
0.27	6600 HK	SCICLONE PHARMAC	BMX5ZW2	1.33	96,800	128,492.57
0.27	AED BB	AEDIFICA	B1G5XP1	70.12	1,812	127,059.20
0.27	NUVA	NUVASIVE INC	B00GJC2	37.12	3,404	126,356.48
0.26	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.44	283,424	124,803.00
0.26	FGEN	FIBROGEN INC	BSDRYR8	16.70	7,401	123,596.70
0.26	AMRN	AMARIN CORP PLC -ADR	2301938	1.19	103,370	123,010.30
0.26	9229 JP	SUNWELS CO LTD	BNTYNB5	20.93	5,819	121,809.88
0.25	BKD	BROOKDALE SR	B0PZN33	3.43	35,032	120,159.76
0.24	PHM SM	PHARMA MAR SA	BMW2GT8	36.89	3,136	115,690.57
0.24	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.31	357,792	111,426.83
0.24	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	30.65	3,627	111,167.55
0.23	1858 HK	BEIJING CHUNLI-H	BVVPXP6	2.01	55,116	110,585.85
0.23	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	1.83	59,702	109,119.21
0.22	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.94	111,189	105,017.79
0.21	2500 HK	VENUS MEDTECH -H	BL6V047	1.03	97,440	100,364.50
0.06		CANADIAN DOLLAR		0.73	36,864	27,020.22
0.01		EURO		1.07	4,022	4,305.83
0.00		BRITISH STERLING POUND		1.17	0	0.07
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.00
0.00		JAPANESE YEN		0.01	-2	-0.01
0.00		SWISS FRANC		1.00	0	-0.02
0.00		AUSTRALIAN DOLLAR		0.62	0	-0.08
-0.20		CASH		1.00	-93,429	-93,428.66

Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 04/30/23

	Sector	Weight (%)
	Health Care	93.9
	Real Estate	6.1

Source: AltaVista Research, LLC

Country Breakdown As of 04/30/23

	Country	Weight (%)
	United States	58.1
	Switzerland	8.6
	Japan	7.1
	Denmark	6.0
	Britain	4.7
	China	4.6
	Ireland	3.6
	Belgium	1.6
	South Korea	1.5
	Germany	1.0
	Australia	0.7
	Other/Cash	2.5

Source: AltaVista Research, LLC

ETF Characteristics As of 05/26/23

Return on Equity	12.00%
Weighted Avg. Market Cap	60,531 M
	2022	2023
Price-to-earnings	25.90	27.06
Price-to-book value	3.37	3.15

Source: AltaVista Research, LLC

ETF Risk Stats As of 04/30/23

Versus	Beta
S&P 500	0.67
NASDAQ-100	0.48
MSCI EAFE	0.69
MSCI Emg. Mkts	0.46
Standard Deviation	15.90%

Source: AltaVista Research, LLC

ETF Research

Diabetes Management: Massive Addressable Market Spurs Innovative Solutions

J.P. Morgan Healthcare Conference: New Catalysts Set to Transform Patient Care

Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023

Latest Premium / Discount As of 05/26/23

NAV	$27.24
Market Price	$27.23
Premium / (Discount)	($0.01)

Current View 2023 Q2 As of 05/26/23

Days at Premium	1
Days at NAV	0
Days at Discount	38
Greatest Premium	0.10%
Greatest Discount	-0.55%

Daily Premium / Discount History As of 05/26/23

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 05/26/23

ETF Summary

ETF Objective

Trading Details As of 05/25/23

Distributions As of 05/26/23

ETF Prices As of 05/26/23

Performance History

Top Holdings As of 05/26/23

Sector Breakdown As of 04/30/23

Country Breakdown As of 04/30/23

ETF Characteristics As of 05/26/23

ETF Risk Stats As of 04/30/23

ETF Research

Diabetes Management: Massive Addressable Market Spurs Innovative Solutions

J.P. Morgan Healthcare Conference: New Catalysts Set to Transform Patient Care

Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023

ETF Documents